CTRI/2020/09/027679尚未招募未知
To assess the effect of canagliflozin in non diabetic proteinuric disease
COMMAND HOSPITAL AIR FORCE BANGALORE0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patient in age group 18 to 75 years, registered in Nephrology OPD and was diagnosed as glomerulonephritis on the basis of renal biopsy and having proteinuria > 1 gm/day
- •Should have e GFR > 25 ml/min/1.73 m2
- •The patient should be on a stable dose of an ACEi or ARB/immunosuppression for at least 4 weeks prior to randomization
排除标准
- •Patient detected to be diabetic prior to enrolment or during the study
- •Patient lost to follow up during the study period
- •Patient whose baseline and follow up laboratory investigations, 24 hr urine protein, detailed renal biopsy report not available
研究者
相似试验
招募中
不适用
Effect of Canagliflozin in Non-diabetic overweight and obesity Patients with albuminuria: A Randomized, Double-blind, Placebo-controlled TrialEffect of Canagliflozin in Non-diabetic overweight and obesity Patients.Canagliflozin and Non-diabetic overweight and obesity PatientsTCTR20190203003Rachadaphiseksompot Endorsement Fund80
已完成
不适用
Study of the beneficial effect of Canagliflozin on nocturnal home BP in Japanese T2DM patients(SHIFT-J STUDY)Type 2 diabetes mellitus patients with hypertensionJPRN-UMIN000023487Jichi Medical University School of Medicine100
已完成
不适用
The effect of canagliflozin on the blood sugar levels of people without diabetes after weight loss surgeryHypoglycaemia after eating due to weight-loss surgerySurgeryISRCTN11342830niversity of Leicester36
进行中（未招募）
1 期
The effect of canagliflozin 300mg on glucose levels in people without diabetes after weight loss surgery.EUCTR2019-004041-32-GBniversity of Leicester24
尚未招募
不适用
Effect of canagliflozin as an alternative drug from DPP-4 inhibitor on heart failure with diabetis melltus : the pilot study "Can canagliflozin HAve Not only hypoGlycemic but cardiac supportive Effect?"chronic heart failure with type 2 diabetis mellitusJPRN-UMIN000031563Osaka Rosai Hospital40